Abbott Laboratories (ABT) â€” Q4 2024 Earnings Call Transcript
Date: January 11, 2025
Participants: CEO, CFO, Head of IR

OPERATOR: Good morning and welcome to the Abbott Laboratories fourth quarter 2024 earnings call.

CEO: Thank you, operator. Good morning everyone. We're pleased to report strong results
for the fourth quarter and full year 2024. Revenue grew 6% year-over-year,
driven by new customer acquisition.

Our key highlights for the quarter include:
- Revenue of $44.5 billion
- Operating margin expansion of 162 basis points
- Free cash flow of $4.8 billion
- Successful product launches

CFO: Thank you. Let me walk through the financial details...

[Transcript continues with Q&A session]

ANALYST Q&A:
Q: Can you provide more color on the margin expansion?
A: Certainly. We saw improvements across all segments...

Q: What's your outlook for 2025?
A: We're cautiously optimistic. Our guidance reflects...

[END OF TRANSCRIPT]
